258 related articles for article (PubMed ID: 24062309)
1. Redox control of the senescence regulator interleukin-1α and the secretory phenotype.
McCarthy DA; Clark RR; Bartling TR; Trebak M; Melendez JA
J Biol Chem; 2013 Nov; 288(45):32149-32159. PubMed ID: 24062309
[TBL] [Abstract][Full Text] [Related]
2. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network.
Orjalo AV; Bhaumik D; Gengler BK; Scott GK; Campisi J
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17031-6. PubMed ID: 19805069
[TBL] [Abstract][Full Text] [Related]
3. Redox-control of the alarmin, Interleukin-1α.
McCarthy DA; Ranganathan A; Subbaram S; Flaherty NL; Patel N; Trebak M; Hempel N; Melendez JA
Redox Biol; 2013; 1(1):218-25. PubMed ID: 24024155
[TBL] [Abstract][Full Text] [Related]
4. S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1α.
Su Y; Xu C; Sun Z; Liang Y; Li G; Tong T; Chen J
Aging (Albany NY); 2019 Jan; 11(2):549-572. PubMed ID: 30670674
[TBL] [Abstract][Full Text] [Related]
5. Redox and mTOR-dependent regulation of plasma lamellar calcium influx controls the senescence-associated secretory phenotype.
Chandrasekaran A; Lee MY; Zhang X; Hasan S; Desta H; Tenenbaum SA; Melendez JA
Exp Biol Med (Maywood); 2020 Nov; 245(17):1560-1570. PubMed ID: 32686475
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.
Laberge RM; Zhou L; Sarantos MR; Rodier F; Freund A; de Keizer PL; Liu S; Demaria M; Cong YS; Kapahi P; Desprez PY; Hughes RE; Campisi J
Aging Cell; 2012 Aug; 11(4):569-78. PubMed ID: 22404905
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg3 Prevents Oxidative Stress-Induced Astrocytic Senescence and Ameliorates Senescence Paracrine Effects on Glioblastoma.
Hou J; Kim S; Sung C; Choi C
Molecules; 2017 Sep; 22(9):. PubMed ID: 28891967
[TBL] [Abstract][Full Text] [Related]
8. IL-1α cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence-associated secretory phenotype.
Wiggins KA; Parry AJ; Cassidy LD; Humphry M; Webster SJ; Goodall JC; Narita M; Clarke MCH
Aging Cell; 2019 Jun; 18(3):e12946. PubMed ID: 30916891
[TBL] [Abstract][Full Text] [Related]
9. Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression.
Pazolli E; Alspach E; Milczarek A; Prior J; Piwnica-Worms D; Stewart SA
Cancer Res; 2012 May; 72(9):2251-61. PubMed ID: 22422937
[TBL] [Abstract][Full Text] [Related]
10. A complex secretory program orchestrated by the inflammasome controls paracrine senescence.
Acosta JC; Banito A; Wuestefeld T; Georgilis A; Janich P; Morton JP; Athineos D; Kang TW; Lasitschka F; Andrulis M; Pascual G; Morris KJ; Khan S; Jin H; Dharmalingam G; Snijders AP; Carroll T; Capper D; Pritchard C; Inman GJ; Longerich T; Sansom OJ; Benitah SA; Zender L; Gil J
Nat Cell Biol; 2013 Aug; 15(8):978-90. PubMed ID: 23770676
[TBL] [Abstract][Full Text] [Related]
11. Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α-Dependent Senescence-Associated Secretory Phenotype.
Gardner SE; Humphry M; Bennett MR; Clarke MC
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1963-74. PubMed ID: 26139463
[TBL] [Abstract][Full Text] [Related]
12. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells.
Perrott KM; Wiley CD; Desprez PY; Campisi J
Geroscience; 2017 Apr; 39(2):161-173. PubMed ID: 28378188
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer.
Nozaki S; Sledge GW; Nakshatri H
Biochem Biophys Res Commun; 2000 Aug; 275(1):60-2. PubMed ID: 10944441
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.
Meyer K; Patra T; Vijayamahantesh ; Ray R
J Virol; 2021 Aug; 95(17):e0079421. PubMed ID: 34160250
[TBL] [Abstract][Full Text] [Related]
15. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
16. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Coppé JP; Patil CK; Rodier F; Sun Y; Muñoz DP; Goldstein J; Nelson PS; Desprez PY; Campisi J
PLoS Biol; 2008 Dec; 6(12):2853-68. PubMed ID: 19053174
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype.
Wiley CD; Schaum N; Alimirah F; Lopez-Dominguez JA; Orjalo AV; Scott G; Desprez PY; Benz C; Davalos AR; Campisi J
Sci Rep; 2018 Feb; 8(1):2410. PubMed ID: 29402901
[TBL] [Abstract][Full Text] [Related]
18. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
19. Paracrine Senescence of Mesenchymal Stromal Cells Involves Inflammatory Cytokines and the NF-κB Pathway.
Chou LY; Ho CT; Hung SC
Cells; 2022 Oct; 11(20):. PubMed ID: 36291189
[TBL] [Abstract][Full Text] [Related]
20. Radiation-Induced Osteocyte Senescence Alters Bone Marrow Mesenchymal Stem Cell Differentiation Potential via Paracrine Signaling.
Xu L; Wang Y; Wang J; Zhai J; Ren L; Zhu G
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
